arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Bright Minds Biosciences Inc.

DRUG Health Care Biotechnology: Pharmaceutical Preparations
$66.46
▲ +2.0% Today
as of Sep 4, 16:48 ET
Last 30 days -9.39% Jul 27 → Sep 04
$63.59 $69.27 $74.95 $80.63 $86.31 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$67.84
High
$69.06
Low
$64.53
Volume
$93,009
Avg Vol
$196,853
Mkt Cap
$775M
P/E (TTM)
—
Beta
—
52w High
$123.75
52w Low
$39.70
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 6 items

Sep 4 · 20:30 PR GlobeNewswire
Bright Minds Biosciences to Present at Upcoming Conferences
Aug 27 · 16:00 Zacks
What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
Aug 26 · 13:55 Zacks
Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
▸ Show all 6 press releases & news Free account →

Overview

52-week range
$40
$124
32% of range
Avg surprise (last 3)
+22.5%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
55%
EM ±8.5% · $65 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.17$-0.95$-0.73$-0.51$-0.29 Actual $-0.29Est $-0.39Actual $-0.53Est $-0.59Actual $-0.80Est $-1.17 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 19, 2026Mar/2026 $-0.80 $-1.17 +31.6% -175.9% -0.6% earnings
Thu Aug 14, 2025Jun/2025 $-0.53 $-0.59 +10.2% — — earnings
Thu May 15, 2025Mar/2025 $-0.29 $-0.39 +25.6% — +2.1% earnings

Implied volatility — last 90 days

54%79%105%130%155% Jul 07 — IV 85% · EM ±11.2%Jul 08 — IV 81% · EM ±10.1%Jul 09 — IV 99% · EM ±11.7%Jul 10 — IV 112% · EM ±12.3%Jul 13 — IV 97% · EM ±8.1%Jul 14 — IV 111% · EM ±8.0%Jul 15 — IV 113% · EM ±6.7%Jul 20 — IV 86% · EM ±20.3%Jul 21 — IV 86% · EM ±19.9%Jul 22 — IV 85% · EM ±19.4%Jul 23 — IV 85% · EM ±19.1%Jul 24 — IV 85% · EM ±18.8%Jul 27 — IV 79% · EM ±16.5%Jul 28 — IV 84% · EM ±17.2%Jul 29 — IV 80% · EM ±16.0%Jul 30 — IV 91% · EM ±17.8%Jul 31 — IV 90% · EM ±17.1%Aug 03 — IV 94% · EM ±16.7%Aug 04 — IV 85% · EM ±14.6%Aug 05 — IV 89% · EM ±14.8%Aug 06 — IV 84% · EM ±13.6%Aug 07 — IV 83% · EM ±12.9%Aug 10 — IV 90% · EM ±12.5%Aug 11 — IV 91% · EM ±12.0%Aug 12 — IV 90% · EM ±11.3%Aug 13 — IV 89% · EM ±10.5%Aug 14 — IV 94% · EM ±10.4%Aug 17 — IV 86% · EM ±7.2%Aug 18 — IV 86% · EM ±6.2%Aug 20 — IV 155% · EM ±6.5%Aug 24 — IV 66% · EM ±13.8%Aug 25 — IV 68% · EM ±13.8%Aug 26 — IV 66% · EM ±13.2%Aug 27 — IV 66% · EM ±12.8%Aug 28 — IV 66% · EM ±12.6%Aug 31 — IV 67% · EM ±11.8%Sep 01 — IV 62% · EM ±10.7%Sep 02 — IV 72% · EM ±12.0%Sep 03 — IV 67% · EM ±10.9%Sep 04 — IV 55% · EM ±8.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in